Document:

EX-10.21(g)

 Exhibit 10.21(g) 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 
 Contract Amendment No. 6 

to the 
 Development and Supply
Agreement as of May 29, 2008 
 by and between 

ViewRay Incorporated 
 with
its registered seat in Oakwood Village, OH, USA 
 — hereinafter referred to as “VIEWRAY OR BUYER” — 

And 
 Siemens AG 

Healthcare Sector 
 —
hereinafter referred to as “SIEMENS OR SELLER” — 
 — VIEWRAY and SIEMENS hereinafter referred to individually 

as “Party” or collectively as “Parties” — 

Preamble 
 The Parties have signed a
Development and Supply Agreement on May 29, 2008, as amended (the “2008 Agreement”) with the intention to collaborate in the development of combining MR imaging and gamma radiotherapy. According to Appendix 2 of the 2008
Agreement as amended (the “SUPPLY AGREEMENT”) SIEMENS delivers certain components as described in Annex 1 to the SUPPLY AGREEMENT (“COMPONENTS”) to VIEWRAY for integration in their MRgRT systems With this Contract Amendment
No. 6, the Parties agree (i) to the delivery of the COMPONENTS for the integration by VIEWRAY in the [***] and (ii) to the provision of limited fee-for-service technical assistance from SIEMENS to VIEWRAY with respect to VIEWRAY
efforts [***]. For the avoidance of doubt, the activities contemplated by this Contract Amendment No. 6 are in addition to the activities of the Parties with respect to the supply of COMPONENTS by SIEMENS to VIEWRAY of MRI subsystems for MRgRT
systems contemplated by the 2008 Agreement. 
 Agreement 

Article 1. COMPONENTS and services for [***] 
 This
Article 1 shall apply to COMPONENTS delivered for [***] but not for COMPONENTS delivered for MRgRT systems, which will continue to be governed by Section 2 of the SUPPLY AGREEMENT. 

 

	1.1	 VIEWRAY shall furnish to SIEMENS a forecast indicating its demand of COMPONENTS for the period of the next [***]
following signature of this Contract Amendment No. 6. If SIEMENS does not object the forecast in writing within fifteen 

	 	
(15) Business Days after receipt of the forecast the forecast will be accepted by SIEMENS and SIEMENS will consider the forecast when planning its production capacities. In this case VIEWRAY may
assume that SIEMENS will accept purchase orders within this scope. VIEWRAY shall place its orders in writing to SIEMENS and SIEMENS shall acknowledge these orders within ten (10) Business Days after receipt thereof, as far as they do not exceed
the forecast accepted by SIEMENS. Section 2.3-2.6 of the Supply Agreement, as well as Articles 2 to 16 of the SUPPLY AGREEMENT shall apply respectively to the delivery of COMPONENTS unless otherwise agreed in this Contract Amendment No. 6.

  

	1.2	SIEMENS will consider reasonable requests for technical assistance services from VIEWRAY concerning COMPONENTS for the [***]. If VIEWRAY requests such technical assistance services and SIEMENS agrees to provide such
technical assistance services itself, or through its wholly-owned indirect U.S. subsidiary, Siemens Medical Solutions USA, Inc., then VIEWRAY shall pay for such technical assistance services at the rates established at the commencement of each
request for services pursuant to this Article 1.2. VIEWRAY shall [***]. For the avoidance of doubt, SIEMENS shall not be obligated to agree to the provision of technical assistance services. The provision of technical assistance services shall be
subject to the terms and conditions of SIEMENS for the provision of services applicable at the commencement of such technical assistance services. 

Article 2. Deviations from the SUPPLY AGREEMENT 
 This
Article 2 shall apply to COMPONENTS delivered for MRgRT systems as well as to COMPONENTS delivered for [***]. 
 Article 10 of the SUPPLY AGREEMENT shall be
deleted and replaced as follows: 
  

	 	“10.1	BUYER shall be responsible for its use of COMPONENTS and shall verify whether such use infringes any third party patent, utility models or copyright (hereinafter “Protective Rights”). 

 

	 	10.2	If a third party raises claims against SELLER and/or its subsidiaries for infringement of Protective Rights that are based on BUYER’S use of the COMPONENTS in its MRgRT systems or [***] (including but not
limited to inducement to infringement and/or contributory infringement), then BUYER shall indemnify and hold harmless SELLER and/or its subsidiaries of any damages, including reasonable attorney fees and other legal costs and expenses as well as
appropriate license fees, incurred by SELLER; for the avoidance of doubt, BUYER shall not be required to indemnify, hold harmless or defend SELLER and/or its subsidiaries against any claim if that claim is (i) solely based on the fact that the
COMPONENT itself infringes a Protective Right and is (ii) independent from the use of the COMPONENT in the MRgRT systems or [***]. 

  

	 	10.3	SELLER does not assume any liability with regard to the MRgRT systems and/or [***] developed and/or sold by BUYER. Section 10.2 shall apply likewise in case 

 
 [***] Certain information in this document has been omitted and filed separately with
the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	
a third party raises claims against SELLER for personal injury, damages to property, loss of business or revenue and/or any other damages caused by the use of the MRgRT systems and/or
[***]. 

  

	 	10.4	In any claim for indemnification under Section 10.2 or Section 10.3, SELLER must give BUYER prompt written notice of any claim or proceeding with respect to which it believes it is entitled to seek
indemnification. The BUYER shall be entitled to assume the defense of such claim with counsel selected by the BUYER and reasonably satisfactory to the SELLER, provided that (i) the SELLER agrees to that assumption of the defense, which
agreement shall not be unreasonably be withheld and (ii) the BUYER acknowledges in writing its obligation to indemnify the SELLER for the claim that is the subject of such notice and that (iii) the defense of such claim takes into account
the reasonable interests of SELLER. Should the BUYER so elect to assume the defense of a claim, the BUYER shall also be liable to the SELLER for legal expenses which SELLER incurs if a separate representation of the SELLER in the settlement is
appropriate because SELLER, in the exercise of its reasonable discretion, has determined that a conflict of interest or reasonable business interests of SELLER make separate representation by the SELLER’S own counsel advisable.

  

	 	    	Notwithstanding the foregoing, if the BUYER assumes such defense, the SELLER may, at its sole option and expense, participate in such defense and employ separate counsel, and further agrees to cooperate in the
conduct of any such defense. 

  

	 	    	If the BUYER assumes such defense, the BUYER shall have the right to settle such claim, in its discretion, with a full release of the SELLER and no admission of liability; provided that the BUYER shall obtain the
written consent prior to settling any claim of the SELLER, such consent not to be unreasonably withheld. The Parties agree that it would not be unreasonable withheld the consent if the SELLER would (i) become subject to injunctive or other
equitable relief, or any monetary or in-kind obligations, or (ii) if the business of the SELLER would be adversely affected in any manner. 

  

	 	    	The BUYER has no obligation to indemnify in connection with any settlement made by SELLER without the BUYER’S written consent, such consent not to be unreasonably withheld.” 

Article 3. Export Control 
 This Article 3 shall apply to
COMPONENTS delivered for MRgRT systems as well as to COMPONENTS delivered for [***]. 
  

	3.1	If VIEWRAY transfers COMPONENTS delivered by SIEMENS or technical assistance services performed by SIEMENS or its wholly-owned indirect U.S. subsidiary, Siemens Medical Solutions USA, Inc. to a third party VIEWRAY shall
comply with all applicable national and international (re-) export control regulations. In any event of such transfer 

  

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

	 	
of COMPONENTS and/or technical assistance services VIEWRAY shall comply with the (re-) export control regulations of the Federal Republic of Germany, of the European Union and of the United
States of America. 

  

	3.2	Prior to any transfer of COMPONENTS and/or technical assistance services provided by SIEMENS or its wholly-owned indirect U.S. subsidiary, Siemens Medical Solutions USA, Inc. to a third party VIEWRAY shall in particular
check and guarantee by appropriate measures that there will be no infringement of an embargo imposed by the European Union, by the United States of America and/or by the United Nations by such transfer, by brokering of contracts concerning those
goods, works and services or by provision of other economic resources in connection with those COMPONENTS and or and/or technical assistance services, also considering the limitations of domestic business and prohibitions of by-passing those
embargos; 

  

	3.3	Such COMPONENTS and/or technical assistance services are not intended for use in connection with armaments, nuclear technology or weapons, if and to the extent such use is subject to prohibition or authorization, unless
required authorization is provided; The regulations of all applicable Sanctioned Party Lists of the European Union and the United States of America concerning the trading with entities, persons and organizations listed therein are considered.

  

	3.4	If required to enable authorities or SIEMENS or its wholly-owned indirect U.S. subsidiary, Siemens Medical Solutions USA, Inc. to conduct export control checks, VIEWRAY, upon request by SIEMENS, shall promptly provide
SIEMENS with all information pertaining to the particular end customer, the particular destination and the particular intended use of goods, works and services provided by SIEMENS, as well as any export control restrictions existing.

  

	3.5	VIEWRAY shall indemnify and hold harmless SIEMENS and its subsidiaries from and against any claim, proceeding, action, fine, loss, cost and damages arising out of or relating to any noncompliance with export control
regulations by VIEWRAY, and VIEWRAY shall compensate SIEMENS and its subsidiaries for all losses and expenses resulting thereof. Section 10.4 shall apply. 

Article 4. Safety 
 This Article 4 shall apply to
COMPONENTS delivered for MRgRT systems as well as for COMPONENTS delivered for [***]. 
  

	4.1	The Parties shall, also beyond the term of the SUPPLY AGREEMENT, collaborate to the best of their abilities in order to prevent identified or unidentified risks or damages as quickly and effectively as possible which
may be caused by the COMPONENTS so that no one suffers any damage or injury as a result of using the COMPONENTS. 

  

	4.2	VIEWRAY shall be obliged to monitor the COMPONENTS used together with its own equipment or systems with regard to product defects of all kinds. The aforesaid obligation shall be carried out by VIEWRAY by appropriate
organizational measures 

  
 [***] Certain information in this document
has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	
within the scope of its organizational and operational structure. VIEWRAY shall promptly notify SIEMENS in writing of any identified product defects in accordance with its quality assurance
policies and procedures, provided that such policies and procedures are reasonably acceptable to SELLER. 

 Article 5. Duration 

This Contract Amendment No. 6 shall take effect on the date it is signed by both Parties and shall be valid until the SUPPLY AGREEMENT is terminated. Each
Party’s right to terminate the SUPPLY AGREEMENT and/or this Contract Amendment No. 6 for good cause, including but not limited to the termination rights under 13.1(b) of the SUPPLY AGREEMENT, shall remain unaffected. 

Article 6. Miscellaneous 
  

	6.1	Except to the extent expressly amended by this Contract Amendment No. 6, all of the clauses and conditions of the 2008 Agreement shall remain unaffected. The term “Agreement”, as used in the 2008
Agreement, shall henceforth be deemed to be a reference to the 2008 Agreement as amended by this Contract Amendment No. 6. 

  

	6.2	This Contract Amendment No. 6 may be executed in counterparts, each of which will be deemed an original with all such counterparts together constituting one instrument. Capitalized terms used in this Contract
Amendment No. 6 and not defined herein are used with the meanings ascribed to them in the 2008 Agreement. 

  

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

			
	ViewRay Incorporated
	
	Place, Date:
	
	 Mtn View, CA 15 Jan, 2014

	
	 /s/ Chris Raanes

		
	Name: 	 	 Chris Raanes

		 	(Print)
	Title:	 	 Chief Executive Officer

 Siemens AG. 

Healthcare Sector 
  

							
	Place, Date:	  		  		  	
				
	 Erlangen, 20.02.2014
	  		  	 Erlangen, 21.02.2014
	  	
				
	 i.V. /s/ Michael Schaal
	  		  	 iV. /s/ Holger Liebel
	  	
				
	Name:	  		  	Name:	  	
				
	 Michael Schaal
	  		  	 Holger Liebel
	  	
	(Print)	  		  	(Print)	  	
	Title:	  		  	Title:	  	
	 Head of H/M MRTR
	  		  	 CFO Magnetic Resonance
	  	

  
 [***] Certain information in this document has been
omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.EX-10.22

 Exhibit 10.22 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 
  

			
		
	 [GRAPHIC APPEARS HERE]
	  	 413 March Road
 Ottawa, ON Canada K2K
0E4
 Phone: [***]
 Fax: [***]

 COBALT-60 SOURCE SUPPLY 

AND REMOVAL AGREEMENT 

BTL/VIEWRAY 2013 
 THIS Agreement is
entered into as of the 19 day of December, is between: 
 Best Theratronics Ltd. 

413 March Road 
 Ottawa, ON 

Canada, K2K 0E4 
 (“Best
Theratronics) 
 and 

ViewRay Incorporated 
 2
Thermo Fisher Way 
 Oakwood, OH 

USA 44146 
 (“ViewRay”)

 WHEREAS, Best Theratronics is engaged in the manufacture and removal of cobalt-60 sources; and 

WHEREAS, ViewRay desires to engage Best Theratronics to (i) manufacture medical cobalt-60 sources for use in ViewRay’s Image Guided Radiation
Therapy System, a medical device manufactured and distributed by ViewRay; and (ii) provide medical cobalt-60 sources removal services for Best Theratronics supplied medical cobalt-60 sources. 

 NOW THEREFORE, in consideration of the mutual covenants and agreements herein contained, and other good
and valuable consideration, the receipt, sufficiency, and adequacy of which are hereby acknowledged, the Parties hereto, intending to be legally bound, contract and agree as follows: 

 

	1.	Definitions: 

 As used in this Agreement, the following terms shall have the
following meaning: 
  

	 	1.1	“Affiliate(s)” means a body corporate, which now or hereafter, is affiliated with another body corporate. One body corporate is affiliated with another body corporate if one of them is the subsidiary of the
other or both are subsidiaries of the same body corporate or each of them is controlled by the same entity; and if two bodies corporate are affiliated with the same body corporate at the same time, they are deemed to be affiliated with each other.

 Subsidiary: a body corporate shall be a subsidiary of another body corporate if it is controlled by that other body
corporate. 
 Control: a body corporate is controlled by a person or other body corporate if securities of the body corporate to which are
attached more than fifty (50%) percent of the votes that may be cast to elect directors of the body corporate, are held other than by way of security only, by or for the benefit of that person or body corporate and the votes attached are
sufficient to elect a majority of the directors of the body corporate. 
  

	 	1.2	“Agreement” shall mean this Cobalt-60 Source Supply and Removal Agreement. 

  

	 	1.3	 “Confidential Information” means all information disclosed by a Party whether disclosed orally, in
writing or other tangible media or tangible form, whether patented, unpatented, patentable or unpatentable or disclosed in patent applications relating to technical or non-technical data, designs, drawings, know-how, formulas, policies, plan
reports, trade secrets, skills, processes, methods, 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	
product development activities, material samples, business plans, forecasts, marketing plans, customer lists, business strategies and other documentation or information of a technical or
financial nature. For purposes hereof, Confidential Information does not include information which: (i) was known to recipient prior to the date hereof or which is information generally available to the public; (ii) hereafter, through no
act on the part of the recipient, becomes information generally available to the public; (iii) is, at the time of the disclosure, in the possession of recipient and was not previously acquired directly or indirectly from the other Party, or any
Affiliate of them on a confidential basis; (iv) the recipient can show was received by it after the time of disclosure hereunder from a third party who did not acquire it directly or indirectly from the other Party or any Affiliate thereof, and
who did not acquire it under an obligation of confidence to the other Party or any Affiliate, provided that the recipient abides by any restriction on disclosure or use imposed by such third party; (v) is approved for release by written consent
of a disclosure; or (vi) is disclosed pursuant to the requirement or request of a governmental agency or by operation of law, provided that the affected Party is reasonably notified in advance of such requirement or request. 

 

	 	1.4	“Source Removal Services” shall mean the services to be rendered by Best Theratronics hereunder for the removal of Medical Cobalt-60 Sources after their useful life. 

 

	 	1.5	“Image Guided Radiation Therapy (IGRT) System” shall mean ViewRay’s medical device for use in radiation therapy. 

  

	 	1.6	“Party” or “Parties” means ViewRay, Best Theratronics, or ViewRay and Best Theratronics. 

  

	 	1.7	“Medical Cobalt-60 Sources” shall mean the C-146 medical cobalt-60 sources manufactured, produced, and supplied by Best Theratronics meeting the Specifications in Exhibit 2. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	1.8	“DDP” and “DAP” shall have the meaning ascribed in the International Chamber of Commerce Incoterms 2010, publication 715ES. 

 

	 	1.9	“Term” shall have the meaning ascribed in section 6.1. 

  

	 	1.10	“Ex-works” shall have the meaning ascribed in the International Chamber of Commerce Incoterms 2010, publication 715ES. 

  

	 	1.11	“CIP” shall have the meaning ascribed in the International Chamber of Commerce Incoterms 2010, publication 715ES. 

  

	 	1.12	“CPT” shall have the meaning ascribed in the International Chamber of Commerce Incoterms 2010, publication 715ES. 

  

	 	1.13	“Specification(s)” shall mean the Medical Cobalt-60 Source specifications set out in Exhibit 2. 

Exhibits 
 Exhibit 1:
Medical Cobalt-60 Sources Price 
 Exhibit 2: Medical Cobalt-60 Sources Specifications 

Exhibit 3: ViewRay Form of Purchase Order 

Exhibit 4: Price/Credit for Medical Cobalt-60 Source Removal 
  

	2.	Confidentiality 

  

	 	2.1	License Grant. During the term of this Agreement, Best Theratronics hereby grants to ViewRay a royalty free, non-exclusive, nontransferable license to use Best Theratronics’ Confidential Information
solely for the purpose of enabling ViewRay to design and manufacture an Image Guided Radiation Therapy (IGRT) System which is compatible with the Medical Cobalt-60 Sources. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	2.2	Confidentiality. With respect to Confidential Information disclosed by either Party, either directly or indirectly: 

  

	 	(a)	all right, title, and interest in and to the Confidential Information shall be retained by the Party supplying the Confidential Information; 

 

	 	(b)	the Confidential Information will be held in strict confidence by the recipient and will not be divulged, disclosed, nor used by recipient in any manner except in accordance with the terms herein; and 

 

	 	(c)	recipient agrees that any Confidential Information received shall only be disclosed to its employees or officers on a “need-to-know” basis and that each such person who has access to any Confidential
Information will be advised to keep the same secret and use the same only in the course of carrying out the work contemplated by this Agreement. 

  

	 	2.3	Use. The recipient, except as otherwise set out and for the purpose of performing its obligations hereunder, shall not, either directly or indirectly, make any use, commercial or otherwise, nor permit any
other persons to make any such use of any part of the Confidential Information supplied by the other Party hereto without first having obtained the other Party’s written consent thereto. The Parties acknowledge that any disclosure or use of the
Confidential Information in breach of this Agreement shall cause irreparable harm for which damages are not an adequate remedy and shall entitle such Party to seek an injunction or other equitable remedy. 

 

	 	2.4	Rights. Except as otherwise set out the disclosure of Confidential Information to the other Party shall not be construed as granting such Party any right or license in any country under any license,
patent, patent application, or other intellectual property right. 

  

	 	2.5	Return. Upon termination of this Agreement, or upon earlier written request by the other Party, recipient will return to the other Party any and all materials in recorded form provided to it containing
Confidential Information together with any copies recipient may have made. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	3.	Manufacture of Medical Cobalt-60 Sources 

  

	 	3.1	Manufacture. Best Theratronics shall manufacture and produce the Medical Cobalt-60 Sources for ViewRay in accordance with the terms set forth herein and shall ensure that all Medical Cobalt-60 Sources
conforms to the Specifications. ViewRay will be supplied a Sealed Source Test Certificate for Medical Cobalt-60 Sources purchased. In the event that Best Theratronics should fail to comply with such standards and Specifications, Best Theratronics
shall bear all direct and reasonable costs and expenses of remedial action so as to meet such standards and Specifications. 

  

	 	3.2	Compliance. Best Theratronics warrants and certifies that it shall manufacture and supply Medical Cobalt-60 Sources in compliance with all applicable laws, ordinances, rules, and regulations.

  

	 	3.3	Forecasts. For each calendar year during the Term of this Agreement in which ViewRay will require Medical Cobalt-60 Sources, ViewRay shall submit to Best Theratronics at least thirty-six (36) months
prior to the subject calendar year, a forecast with respect to Medical Cobalt-60 Sources that may be manufactured, supplied, and delivered hereunder during such calendar year. 

 

	4.	Purchase of Medical Cobalt-60 Sources 

  

	 	4.1	Price and Purchase Quantity. 

  

	 	(a)	Best Theratronics agrees to sell Medical Cobalt-60 Sources to ViewRay and ViewRay agrees to purchase Medical Cobalt-60 Sources at the list price set forth in Exhibit 1 (and subject to the terms and conditions set out in
this Agreement). 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	(b)	During the Term of this Agreement, ViewRay agrees to purchase from Best Theratronics a minimum of [***] percent ([***]%) of its requirements for Medical Cobalt-60 Sources in each calendar year (the “Minimum
Requirement”), to the extent that Best Theratronics has the capacity to produce such Medical Cobalt-60 Sources. If at any time Best Theratronics does not have the capacity to provide the Minimum Requirement of Medical Cobalt-60 Sources, ViewRay
may purchase the Medical Cobalt-60 Sources, which Best Theratronics does not have the capacity to provide, from other suppliers without penalty hereunder. ViewRay shall provide to Best Theratronics, within thirty (30) days of the completion of
each calendar year during the Term of this Agreement a certificate issued by its Chief Financial Officer attesting to the fulfillment by ViewRay of the minimum purchase commitment of ViewRay pursuant to this section 4.1 (b). 

 

	 	(c)	Best Theratronics agrees to maintain, on a best effort basis, a Medical Cobalt-60 Sources manufacturing capacity to produce a minimum contingent of Medical Cobalt-60 Sources ( ) per calendar year, as follows:

  

	 	  	                                    
            2014 [***] 

  

	 	  	                                    
            2015 [***] 

  

	 	  	                                    
            2016 [***] 

  

	 	  	For each calendar year during the Term of this Agreement in which Best Theratronics will produce Medical Cobalt-60 Sources, Best Theratronics shall submit to ViewRay at least twelve (12) months prior to the subject
calendar year, a forecast with respect to any increased capacity above the minimum stated herein, during such calendar year. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	(d)	ViewRay shall place orders for the Medical Cobalt-60 Sources with Best Theratronics from time to time pursuant to ViewRay’s purchase order, the form of which is set out in Exhibit 3. The standard terms and
conditions appearing on the reverse of such purchase order and/or those terms and conditions different from the terms and conditions appearing in this Agreement, shall not apply. Best Theratronics, following its acceptance of such orders, shall fill
and deliver all such orders in accordance with the terms hereof and shall invoice ViewRay for all orders. Best Theratronics will provide ViewRay a written order acknowledgement within thirty (30) days after receipt of ViewRay’s order.

  

	 	4.2	Payment terms. Best Theratronics shall submit invoices to ViewRay for Medical Cobalt-60 Sources delivered to ViewRay hereunder. Best Theratronics’ invoices shall show the name of the ViewRay customer
(if known) and ViewRay’s purchase order number. If any sales, use, duty, excise, or other similar tax or charge for which ViewRay has not furnished or agreed to furnish an exemption certificate is applicable to a particular invoice, it shall be
stated separately on the invoice and shall be to ViewRay’s account. ViewRay retains the right to receive copies of invoices of all sales, use, duty, excise, or other similar tax or charge charged to its account. Best Theratronics shall be
entitled to invoice ViewRay after delivery of the Medical Cobalt-60 Sources North America DAP to ViewRay’s site, its customer’s site or airport/port of destination, as the case may be or for the rest of the world CIP or CPT to airport/port
of destination, as the case may be. Except as otherwise set out, ViewRay shall pay all invoices for Medical Cobalt-60 Sources and services in this Agreement [***]% with the placement of the order, [***]% a minimum of 15 days prior to the start of
the month in which the sources will be manufactured, and [***]% 30 days from the date of shipment. ViewRay agrees that late payments under this Agreement shall accrue annual interest (payable monthly) at the prime lending rate, plus 3%, as published
by the Canadian Imperial Bank of Commerce in Ottawa, Ontario. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	4.3	Shipping and Delivery. Unless otherwise agreed by the Parties hereto: (i) Best Theratronics agrees to deliver the Medical Cobalt-60 Sources to ViewRay’s site or its customer site in North America
DAP to site, (ii) Best Theratronics agrees to deliver the Medical Cobalt-60 Sources to ViewRay’s site or its customer site outside of North America CIP or CPT ports of destination. Title in and risk of loss and damage to the Medical
Cobalt-60 Sources for deliveries in North America shall pass to ViewRay DAP ViewRay’s site or its customer site. For deliveries outside North America title in and risk of loss and damage to the Medical Cobalt-60 Sources shall pass to ViewRay
CIP or CPT ports of destination. The delivery date will be on or about the delivery date agreed, which agreed date shall not be less than ninety (90) days after the date of receipt and acceptance of ViewRay’s purchase order by Best
Theratronics for North American destinations and one hundred and twenty (120) days for destinations outside North America. Best Theratronics will take all commercially reasonable efforts to ensure Medical Cobalt-60 Sources are delivered on the
date requested by ViewRay. All shipping expenses that have been prepaid by Best Theratronics shall be invoiced, at cost, to ViewRay. ViewRay retains the right to receive copies of invoices of all shipping costs charged to its account. All rigging
costs and arrangements for unloading, moving and handling the shipping container(s) at ViewRay’s site, its customer’s site or ports of destination shall be borne by and be the responsibility of ViewRay. 

 

	 	4.4	Highway Transport Notification. Best Theratronics will provide the necessary notifications for the transport of “Highway Route Controlled Quantities” of Medical Cobalt-60 Sources to USDOT as per
49CFR and to other US Authorities as per USNRC “Recommendations for Shipment of Radioactive Material Exceeding Highway Route Controlled Quantity”. 

  

	 	4.5	Shipping Containers and Tool Kits Return. In connection with the delivery of the Medical Cobalt-60 Sources, the Parties acknowledge and agree that Best Theratronics will load the Medical Cobalt-60 Sources
into a certified Best Theratronics container or certified ViewRay container if provided by ViewRay. Rental of Best Theratronics’ type F-147 shipping container(s) with a maximum licensed capacity of 15,000 Curies each is included in the price.
The Best Theratronics shipping container(s) are and shall at all times remain the property of Best Theratronics. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	  	Return shipping of empty or loaded shipping containers shall be arranged by Best Theratronics for and on behalf of ViewRay and charges therefore, will be prepaid by Best Theratronics. All shipping costs, insurance,
duties, customs charges, sales, use, excise or other similar charges incurred by Best Theratronics, shall be to ViewRay’s account. ViewRay retains the right to receive copies of invoices of all shipping costs charged to its account.

  

	 	  	Retention of the shipping containers by ViewRay or its customer beyond thirty (30) days after receipt of the containers at ViewRay’s or its customer’s site is subject to a charge of $[***] CAD per
container per day, invoiced to and payable by ViewRay. 

  

	 	4.6	Licensing. ViewRay shall ensure that its customers send to Best Theratronics (Attention: Customer Service) a copy of their current radioactive materials license (and import license, if applicable),
complete with amendments or similar documentation from the relevant competent authority, stipulating that the Medical Cobalt-60 Sources and associated radioactivity is permitted on-site. Such license must be provided in a timely manner to ensure
adequate time for Best Theratronics to apply for a radioactive material export license, and any other licenses or permits as may be required. It is ViewRay’s responsibility to obtain the required specific license to import or export, from the
country of end-use, Medical Cobalt-60 Sources as required. An export license must be provided prior to shipment to Canada of disused Medial Cobalt-60 Sources. Best Theratronics is responsible for obtaining the license to export the Medical Cobalt-60
Sources from Canada. ViewRay acknowledges that Best Theratronics cannot release the Medical Cobalt-60 Sources for shipment until all required regulatory licenses have been obtained by Best Theratronics. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	4.7	Inspection. The Medical Cobalt-60 Sources shall be inspected by ViewRay or its designate upon their arrival at ViewRay’s customer site (but in no case more than thirty (30) days after the date of
receipt of the Medical Cobalt 60 Sources at ViewRay’s or it’s customer’s site) and shall give written notice to Best Theratronics of any claim that the Medical Cobalt-60 Sources do not conform to the Specifications or the accepted
purchase order. 

  

	 	4.8	Warranty. Best Theratronics warrants, as per Best Theratronics Standard Terms and Conditions of sale, for a period of one (1) year from the date of delivery that the Medical Cobalt-60 Sources supplied
by Best Theratronics will be free from defects in manufacture, material and workmanship. During the warranty period, Best Theratronics shall repair or replace, at its option, any defective Medical Cobalt-60 Sources. ViewRay shall, at Best
Theratronics’ request, return (at Best Theratronics’ expense) such defective Medical Cobalt-60 Sources to Best Theratronics’ facility in Ottawa, Ontario for repair or replacement. Best Theratronics shall reimburse ViewRay for all
reasonable costs incurred by ViewRay in connection with the delivery, handling, storage, and return of such Medical Cobalt-60 Sources. Such warranty shall not apply in the event the Medical Cobalt-60 Sources are subject to accident, abuse, misuse,
alteration or neglect. 

  

	 	4.9	Disclaimer. ViewRay acknowledges that Best Theratronics is manufacturing and supplying Medical Cobalt-60 Sources to meet Specification and all relevant government and regulatory requirements. Except as
expressly set out in this Agreement, Best Theratronics hereby disclaims all other warranties or conditions express or implied, statutory or otherwise, including but not limited to, any implied warranties or conditions of merchantability or fitness
for a particular purpose. 

  

	5.	Source Removal Services: Terms and Conditions 

  

	 	5.1	Source Removal. Any Medical Cobalt 60 Sources supplied by Best Theratronics during the Term of this Agreement, must be returned to Best Theratronics, subject to and in accordance with the terms of this
Agreement. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	5.2	Purchase Orders. ViewRay may place orders for Source Removal Services with Best Theratronics from time to time pursuant to ViewRay’s standard purchase order (Exhibit 3). The standard terms and
conditions appearing on the reverse of such purchase order and/or those terms and conditions different from the terms and conditions appearing in this Agreement, shall not apply. Best Theratronics, shall fulfill such services in accordance with the
terms hereof. 

  

	 	5.3	Returns/Return Credit. For Medical Cobalt 60 Sources received by Best Theratronics during the Term of this Agreement, Best Theratronics shall, as applicable, charge ViewRay the price or provide the credit,
as set out in Exhibit 4. For the purpose of calculation of the credit, the number of curies of Medical Cobalt 60 received by Best Theratronics shall be determined as of the date of arrival at Best Theratronics’ facility in Ottawa, Ontario,
Canada, or other designated site. During the Term of this Agreement and thereafter Best Theratronics will accept return of Medical Cobalt 60 Sources supplied by Best Theratronics to ViewRay during the term of this Agreement in accordance with
Exhibit 4. If requested, Best Theratronics’ technical personnel labor fees for Source Removal Services (as applicable at the time of rendering such services), other on site services, travel and accommodation expenses, shall be to ViewRay’s
account. 

  

	 	5.4	Invoices/Credit Note. Best Theratronics shall submit invoices (or a credit note as the case may be) to ViewRay for Source Removal Services provided to ViewRay hereunder upon receipt of the returned
source(s) by Best Theratronics at its facility in Ottawa, Ontario, or other designated site in Canada. Best Theratronics’ invoices shall show the name of the ViewRay customer from whom the Medical Cobalt-60 Sources were shipped, the location
from which such Medical Cobalt-60 Sources were shipped and ViewRay’s purchase order number, provided such information is made available to Best Theratronics by ViewRay. ViewRay shall pay all invoices within thirty (30) days of the date of
invoice. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	5.5	Delivery. Unless otherwise agreed by the Parties hereto: (i) transfer of title in and risk of loss and damage to Medical Cobalt-60 Sources for removal from North American sites shall be Ex Works
ViewRay’s site or its customer site, when the returned shipment is prepared by Best Theratronics, (ii) for removal of Medical Cobalt-60 Sources from ViewRay’s site or its customer site outside of North America transfer of title in and
risk of loss and damage to Medical Cobalt-60 Sources shall pass to Best Theratronics upon arrival at the Canadian port of entry. All rigging costs and arrangements for loading, moving and handling shipping container(s) at ViewRay’s site, its
customer’s site, or ports of entry in connection with Source Removal Services, shall be borne by and be the responsibility of ViewRay. 

  

	 	5.6	Warranty. Best Theratronics warrants and certifies that any Source Removal Services provided hereunder shall be carried out in compliance with all applicable laws, ordinances, rules and regulations.

  

	6.	Term and Termination 

  

	 	6.1	Term. The term of this Agreement shall commence on Oct 01, 2013 and shall continue until December 31, 2016 (the “Term”). The agreement may be extended for subsequent one year terms upon
mutual agreement of the Parties 36 months prior to the end of the current Term. 

  

	 	6.2	Termination by ViewRay. ViewRay may, at its option in addition to any remedy it may have, terminate this Agreement effective immediately if any of the following events shall occur: 

 

	 	(a)	Best Theratronics fails to cure a material breach under this Agreement within thirty (30) days after ViewRay has given Best Theratronics written notice of such breach; 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	(b)	Best Theratronics files a petition in bankruptcy, is adjudicated a bankrupt, or files a petition or otherwise seeks relief under or pursuant to any bankruptcy, insolvency, or reorganization statute or proceeding or if a
petition in bankruptcy is filed against Best Theratronics which is not dismissed within forty-five (45) days, or proceedings are taken to liquidate Best Theratronics’ assets. 

 

	 	6.3	Termination by Best Theratronics. Best Theratronics may, at its option in addition to any remedy it may have, terminate this Agreement effective immediately if any of the following events shall occur:

  

	 	(a)	ViewRay fails to pay, when due, without cause, any invoice for Medical Cobalt-60 Sources or Source Removal Services from Best Theratronics, and such delinquency continues for a period of thirty (30) days following
ViewRay’s receipt of written notice of such delinquency; 

  

	 	(b)	ViewRay fails to cure a material breach under this Agreement within thirty (30) days after Best Theratronics has given ViewRay written notice of such breach; 

 

	 	(c)	ViewRay files a petition in bankruptcy, is adjudicated a bankrupt, or files a petition or otherwise seeks relief under or pursuant to any bankruptcy, insolvency, or reorganization statute or proceeding or if a petition
in bankruptcy is filed against ViewRay which is not dismissed within forty-five (45) days, or proceedings are taken to liquidate ViewRay’s assets. 

  

	 	6.4	Termination by either Party. Either Party, at its option, may at any time terminate this agreement by providing the other Party two (2) years prior written notice. 

 

	7.	Price Increases During the Term of this Agreement 

  

	  	Price per curie is set forth in Exhibit 1 and covers pricing for 2014 and 2015. The Parties shall agree to prices for deliveries in calendar year 2016, and subsequent years, 12 months in advance of the start of the new
calendar year. If such agreement cannot be reached, the Agreement shall terminate at the end of the period for which prices have been agreed. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	  	Upon mutual agreement, the Parties may agree to an extended period for agreement of the annual price increase. 

  

	8.	Indemnification 

  

	 	8.1	Best Theratronics Indemnification Obligation. Best Theratronics agrees to indemnify, defend and hold ViewRay and its Affiliates and their respective directors, officers, employees and agents, harmless from
and against any damages, claims, liabilities and expenses (including, but not limited to, reasonable attorney’s fees) resulting from any third party claims or suits (“General Claims Against ViewRay”) arising out of (a) Best
Theratronics’ manufacture, handling, storage, labeling, packaging, preparation or transport for shipment of Medical Cobalt-60 Sources; (b) Best Theratronics’ negligent acts or omissions or willful misconduct; (c) Best
Theratronics’ Source Removal Services, or (d) any failure of the Medical Cobalt-60 Sources to meet the Specifications or applicable laws, ordinances, rules and regulations. Notwithstanding the foregoing, Best Theratronics will not be
required to indemnify, defend and hold ViewRay and its Affiliates and their respective directors, officers, employees and agents harmless from and against any General Claims Against ViewRay to the extent that such claims arise out of
(i) ViewRay’s negligent acts or omissions or willful misconduct; or (ii) ViewRay’s or third party’s improper use, handling or transport of Medical Cobalt-60 Sources. Notwithstanding anything in this section 8.1,
“General Claims Against ViewRay” shall not include “IP Claims Against ViewRay” as described in section 8.4. 

  

	 	8.2	ViewRay Indemnification Obligation. ViewRay agrees to indemnify, defend and hold Best Theratronics and its Affiliates and their respective directors, officers, employees and agents, harmless from and
against any damages, claims, liabilities and expenses (including, but not limited to, reasonable attorney’s fees) resulting from any third party claims or suits (“General Claims Against Best 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	
Theratronics”) arising out of (a) ViewRay’s or its customer’s improper use handling or transport of Medical Cobalt-60 Sources, (b) ViewRay’s activities with respect
to the Source Removal Services provided by Best Theratronics (c) ViewRay’s or its customers use of the Image Guided Radiation Therapy (IGRT) System or (d) ViewRay’s negligent acts or omissions or willful misconduct.
Notwithstanding the foregoing, ViewRay will not be required to indemnify, defend and hold Best Theratronics and its Affiliates and their respective directors, officers, employees and agents harmless from and against any General Claims Against Best
Theratronics to the extent that such claims arise out of (i) Best Theratronics’ negligent acts or omissions or willful misconduct; (ii) any failure of Best Theratronics to manufacture, handle, store, label, package, prepare for
shipment or transport of Medical Cobalt-60 Sources in accordance with this Agreement, or (iii) any failure of Best Theratronics to manufacture Medical Cobalt-60 Sources in accordance with the Specifications or applicable laws, ordinances, rules
and regulations. Notwithstanding anything in this section 8.2, “General Claims Against Best Theratronics” shall not include “IP Claims Against Best Theratronics” as described in section 8.3. 

 

	 	8.3	Intellectual Property Claims Against Best Theratronics. ViewRay agrees to indemnify, defend and hold Best Theratronics and its Affiliates and their respective directors, officers, employees and agents,
harmless from and against any damages, claims, liabilities and expenses (including, but not limited to, reasonable attorneys’ fees) resulting from any third party claims or suits arising out of any proceeding instituted by or on behalf of a
third party based upon a claim that the Image Guided Radiation Therapy (IGRT) System (alone or in combination with the Medical Cobalt 60 Sources) or associated technology, manufactured, sold or used, infringes a patent or any other intellectual
property right of a third party (“IP Claims Against Best Theratronics”). 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	8.4	Intellectual Property Claims Against ViewRay. Best Theratronics agrees to indemnify, defend and hold harmless ViewRay and its Affiliates, and their respective directors, officers, employees and agents from
and against any 

	 	damages, claims, liabilities and expenses (including, but not limited to, reasonable attorney’s fees) resulting from any third party claims or suits arising out of any proceeding instituted by or on behalf of a
third party based upon a claim that the Medical Cobalt-60 Sources or the method of manufacture of Medical Cobalt-60 Sources to the extent developed or contributed by Best Theratronics, infringes a patent or other intellectual property right of a
third party (“IP Claims Against ViewRay”). 

  

	 	8.5	Indemnification Procedures. A party (the “Indemnitee”) intending to claim indemnification under this Agreement shall promptly notify the other party (the “Indemnitor”) in writing of any
action, claim or other matter in respect of which the Indemnitee or any of its directors, officers, employees or agents intend to claim such indemnification; provided, however, the failure to provide such notice within a reasonable period of time
shall not relieve the Indemnitor of any of its obligations hereunder except to the extent the Indemnitor is materially prejudiced by such failure. The Indemnitor shall be entitled to control the defense of and/or settle any such action, claim or
other matter. The Indemnitee agrees to the complete control of such defense or settlement by the Indemnitor, provided, however, any settlement of such claims shall require the Indemnitee’s prior written consent unless such settlement includes a
full release of the Indemnitee, in which case no consent shall be required. The Indemnitee and its directors, officers, employees and agents shall co-operate fully with the Indemnitor and its legal representatives in the investigation and defense of
any action, claim or other matter covered by this indemnification. The Indemnitee shall have the right, but not the obligation, to be represented by counsel of its own selection and at its own expense. 

 

	 	8.6	Limitations on Liability. Except with respect to the beach of confidentiality and obligations of indemnification set out in this Agreement, neither Party shall be liable to the other for indirect,
contingent, special, or consequential damages, including but not limited to loss of profit, loss of time, or loss of opportunity. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	9.	Insurance. Commencing with the supply of Medical Cobalt —60 Sources pursuant to this Agreement, during the term of this Agreement and so long as the Medical Cobalt-60 Sources remain in use,
ViewRay shall maintain Comprehensive General Liability Insurance (including product liability) to the extent of at least one million United States dollars (US $1,000,000) per occurrence and ten million United States Dollars in aggregate (US
$10,000,000). ViewRay shall cause Best Theratronics to be named as an “additional insured” under ViewRay’s liability insurance policy. ViewRay shall, upon reasonable request, provide to Best Theratronics written evidence of
ViewRay’s compliance with the provisions of this Section 9. 

  

	10.	Force Majeure. Neither Party shall be liable to the other for failure to perform or delay in performing its obligations under the Agreement by virtue of an occurrence of an event of Force Majeure. In the
event of Force Majeure, each party shall promptly notify the other Party and shall exert commercially reasonable efforts to eliminate, cure or overcome such event and to resume performance of its obligations. “Force Majeure” shall mean any
occurrence which prevents, delays or interferes with the performance by a Party of any of its obligations hereunder if such event occurs by reason of an act of God, flood, power failure, fire, explosion, casualty, accident, war, revolution, civil
commotion acts of public enemies or terrorism, failure of usual suppliers to provide materials, equipment or machinery, interruption of or delay in transportation, strike or labor disruption or other similar cause beyond the reasonable control of
the other Party. If such event of Force Majeure prevents performance by a Party under this Agreement for a period in excess of one hundred and eighty (180) days, the other Party may terminate this Agreement upon thirty (30) days written
notice, without penalty or liability. 

  

	11.	Notices and Requests. Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be communicated by certified mail, return receipt requested, or by facsimile, to
the Parties hereto at the respective addresses shown below, or at such other address as any such party may designate by notice given to the other Party: 

  

			
		
	 TO:     ViewRay Incorporated

            2 Thermo Fisher Way

            Oakwood, OH

            USA 44146

            Attention:   Chris A Raanes

   President & CEO

            Tel: [***]
	  	 TO:      Best Theratronics

            413 March Road

            Ottawa, Ontario, CANADA

            K2K 0E4

            Attention:   [***]

   Director, Engineering

            Tel: [***]

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	12.	Miscellaneous 

 12.1 Survival. Sections 2.2-2.5, 4.9, 8, 9,
12.2-12.3, and 13 and those sections which by their nature are to survive, shall survive termination or expiration of this Agreement. 
 12.2
Assignment. It is mutually agreed that this Agreement shall not be assigned, pledged, mortgaged or otherwise transferred or disposed of by the Parties hereto in whole or in part, without the prior written consent of both Parties, which
will not be unreasonably withheld. Provided however, either Party shall be free to assign its rights and delegate its obligations under this Agreement to an Affiliate of such party. In the event of assignment to an Affiliate, the assigning Party and
the Affiliate will remain jointly and severally responsible for the obligations. 
 12.3 Waiver. Neither Party shall be deemed
to have waived any of its rights, powers, or remedies under this Agreement, or at law or in equity, unless such waiver is in writing and is executed by it. No delay or omissions by either party in exercising any right, power, or remedy shall operate
as a waiver thereof or of any other right, power or remedy. No waiver by either party of any default shall operate as a waiver of any other default or of the same default on another occasion. 

12.4 Entire Agreement. This Agreement constitutes the entire agreement among the Parties hereto and supersedes and cancels any
prior agreements among the Parties hereto relating to the transactions contemplated hereby or the subject matter herein. This Agreement shall not be modified, except in writing executed by ViewRay and Best Theratronics. 

12.5 Headings. The Section and other headings in this Agreement are inserted solely as a matter of convenience and for reference.

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 12.6 Counterparts. This Agreement may be executed in counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 12.7 Exhibits. All
Exhibits attached hereto are incorporated herein by reference. 
 12.8 Attorneys Fees and Costs. If any litigation is commenced
by either party concerning this Agreement, the party which substantially prevails in such litigation will be entitled to a judgment against the other party for the costs of such litigation, including court costs and reasonable attorneys’ fees.

 12.9 Severability. Every provision of this Agreement is intended to be severable. If any term or provision hereof is illegal
or invalid for any reason whatever, such illegality or invalidity shall not affect the validity of the remainder of the Agreement. 
 12.10
Time. Each Party will use its best efforts to communicate as necessary with the other Party in a timely manner in connection with this Agreement. 
  

	13.	Governing Law. This Agreement shall be governed by and construed in accordance with the laws of Ontario, Canada without reference to its principles on conflicts of laws. The application of the United
Nations Convention for the International Sale of Goods is expressly excluded from this Agreement. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 IN WITNESS WHEREOF, the parites have duly executed this Agreement as of the date first written above.

  

			
	ViewRay Incorporated
		
	Signature:	 	/s/ Chris A. Raanes
		 	 Name: Chris A. Raanes
 Title:
President & CEO

  

			
	Best Theratronics Ltd.
		
	Signature:	 	/s/ Krishnan Suthanthiran
		 	 Name: Krishnan Suthanthiran
 Title:
President

 Agreement/ViewRay/Draft/ 
  

	14.	The Best Theratronics Standard Terms and Condition of Sale form part of this agreement and supersedes any other Terms and Conditions. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 EXHIBIT 1 

Medical Cobalt-60 Source Prices 
  

			
	Number of Sources	  	Price per Curie for shipments in
		  	[***]
		
	[***]	  	[***]

 Note: pricing thereafter subject to escalation pursuant to Section 7. 

All prices are in [***]. 
  

					
	 	  	 Price per Curie for shipments

in [***]

	  	 Price per Curie for shipments in

[***]

			
	[***]	  	[***]	  	[***]

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 EXHIBIT 2 

[***] 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 Exhibit 3 

ViewRay Form of Purchase Order 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 Exhibit 4 

Price/Credit for Medical Cobalt-6- Source Removal 

During the Term of this Agreement, Best Theratronics will use the following pricing/credit schedule for the removal of Medical Cobalt-60 Sources supplied by
Best Theratronics: 
 a) Please refer to the following table for applicable credits for Medical Cobalt-60 Sources received from ViewRay by Best Theratronics.
Credits are only applicable to the future purchase by ViewRay of Medical Cobalt-60 Sources from Best Theratronics pursuant to this Agreement. For the purpose of calculation of the credit, the number of curies of Medical Cobalt-60 received shall be
determined as of the date of arrival at Best Theratronics’ facility in Ottawa, Ontario, Canada or other designated site. 
 b) For Medical Cobalt-60
sources received from ViewRay by Best Theratronics after [***] from the original ship date and with the purchase of a replacement source, ViewRay will be invoiced $[***] per Medical Cobalt-60 Source received. 

c) For Medical Cobalt-60 sources received from ViewRay by Best Theratronics after [***] from the original ship date and without the purchase of a replacement
source, ViewRay will be invoiced $[***] per Medical Cobalt-60 Source received. 
 d) Medical Cobalt-60 Sources returned to Best Theratronics beyond the Term
of the Agreement will be subject to the [***] issued by Best Theratronics upon request from ViewRay for removal of Medical Cobalt-60 Sources. 
 All
prices/credits are in [***]. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

			
	 Return Time Frame
	  	Credit Amount Per Curie
[***] Per Source
	Cobalt-60 sources received after [***] from original date of shipment	  	[***]
	Cobalt-60 sources received after [***] but before [***] from original date of shipment	  	[***]
	Cobalt-60 sources received after [***] but before [***] from original date of shipment	  	[***]

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}]]